Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dorota Sprus-Lipka
Observed name:
Sprus-Lipka Dorota
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0009-0006-6203-622X
Observed ORCID:
0009-0006-6203-622X
OpenAlex ID:
A5117699337
Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
2025
·
Jarosz-Biej Magdalena
, Czapla Justyna
, et al.
·
Cancer Immunology Immunotherapy
·
7
TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High–Dose–Rate Brachytherapy
2026
·
Magdalena Jarosz-Biej
, Ryszard Smolarczyk
, et al.
·
Cancers
·
2
PDF
Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
2025
·
Magdalena Jarosz-Biej
, Justyna Czapla
, et al.
·
Cancer Immunology Immunotherapy
·
2
PDF
Show more works
View as search
Works count:
3
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type